Targeted therapies; who detects the target?

Added value of tumor-stroma ratio to postsurgery circulating tumor DNA and pTN stage in risk stratification of patients with stage III colon cancer treated with adjuvant chemotherapy.

ESMO open·2026

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.

BMC cancer·2022

Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics.

ESMO open·2022

Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study.

BMC cancer·2020

Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing.

Scientific reports·2020

Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.

The American journal of gastroenterology·2019

Oral cancer genesis and progression: DNA near-diploid aneuploidization and endoreduplication by high resolution flow cytometry.

Cellular oncology : the official journal of the International Society for Cellular Oncology·2010

NFAT and AP1 are essential for the expression of a glioblastoma multiforme related IL-13Ra2 transcript.

Cellular oncology : the official journal of the International Society for Cellular Oncology·2010

Loss of CDC4/FBXW7 in gastric carcinoma.

Cellular oncology : the official journal of the International Society for Cellular Oncology·2010

Expression profile of tyrosine phosphatases in HER2 breast cancer cells and tumors.

Cellular oncology : the official journal of the International Society for Cellular Oncology·2010

Oncogenic K-ras activates p38 to maintain colorectal cancer cell proliferation during MEK inhibition.

Cellular oncology : the official journal of the International Society for Cellular Oncology·2010

In vitro effects of oestrogens, antioestrogens and SERMs on pancreatic solid pseudopapillary neoplasm-derived primary cell culture.

Cellular oncology : the official journal of the International Society for Cellular Oncology·2010

FUNDC1-mediated mitochondrial quality control protects against immune checkpoint inhibitor-associated cardiac injury.

Immunologic research·2026

Ferroptosis suppression by MYC confers oxaliplatin resistance in colorectal cancer via FTH1 and GPX4.

Cancer chemotherapy and pharmacology·2026

EID1 blockade potentiates immunosurveillance against cancer metastasis via FPR1-mediated DC-NK crosstalk.

Science China. Life sciences·2026

Distinct Gut Microbiome and Metabolome Profiles Associate with Differential Responses to Immunotherapy in Colorectal Cancer.

Polish journal of microbiology·2026

AI-Driven Multiomics Biomarkers for Precision Oncology: Navigating the Translational Gap and Regulatory Hurdles.

Omics : a journal of integrative biology·2026

Long non-coding RNA LOC101926915-encoded micropeptide carboplatin-induced upregulation factor confers carboplatin resistance in ovarian cancer.

CytoJournal·2026

Related Experiment Videos

Targeted therapies; who detects the target?

Related Concept Videos

Added value of tumor-stroma ratio to postsurgery circulating tumor DNA and pTN stage in risk stratification of patients with stage III colon cancer treated with adjuvant chemotherapy.

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.

Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics.

Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study.

Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing.

Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.

Oral cancer genesis and progression: DNA near-diploid aneuploidization and endoreduplication by high resolution flow cytometry.

NFAT and AP1 are essential for the expression of a glioblastoma multiforme related IL-13Ra2 transcript.

Loss of CDC4/FBXW7 in gastric carcinoma.

Expression profile of tyrosine phosphatases in HER2 breast cancer cells and tumors.

Oncogenic K-ras activates p38 to maintain colorectal cancer cell proliferation during MEK inhibition.

In vitro effects of oestrogens, antioestrogens and SERMs on pancreatic solid pseudopapillary neoplasm-derived primary cell culture.

FUNDC1-mediated mitochondrial quality control protects against immune checkpoint inhibitor-associated cardiac injury.

Ferroptosis suppression by MYC confers oxaliplatin resistance in colorectal cancer via FTH1 and GPX4.

EID1 blockade potentiates immunosurveillance against cancer metastasis via FPR1-mediated DC-NK crosstalk.

Distinct Gut Microbiome and Metabolome Profiles Associate with Differential Responses to Immunotherapy in Colorectal Cancer.

AI-Driven Multiomics Biomarkers for Precision Oncology: Navigating the Translational Gap and Regulatory Hurdles.

Long non-coding RNA LOC101926915-encoded micropeptide carboplatin-induced upregulation factor confers carboplatin resistance in ovarian cancer.

Related Experiment Videos

Targeted therapies; who detects the target?

Related Concept Videos

Related Articles